Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr 5;2(1):76-81.
eCollection 2014.

Glomerular sparing pattern in primary kidney neoplasms: clinical, morphological and immunohistochemical study

Affiliations

Glomerular sparing pattern in primary kidney neoplasms: clinical, morphological and immunohistochemical study

Faisal M Huq Ronny et al. Am J Clin Exp Urol. .

Abstract

Glomerular sparing (GS) is defined as a unique growth pattern in which tumor cells replace the majority of renal tubes and overrun intact glomeruli. This phenomenon has been well recognized by pathologists as a typical infiltrative pattern and some studies suggested it was an independent risk factor. Here, we study the clinical, pathological, and immunohistochemical features of primary kidney neoplasms with glomerular sparing pattern. We searched the archives of our pathology department for nephrectomy specimens and reviewed all pathology reports from 2009-2013. We selected cases with tumor and collected clinicopathological information, focusing on re-evaluation of cases with glomerular sparing pattern. To facilitate our study we performed immunohistochemical stains of PAX-8, p63, and InI-1 on selected cases. We selected a total of 204 nephrectomy cases in this study, including 163 cases of renal cell carcinoma; 37 cases of urothelial carcinoma; 4 cases from other categories (Wilms tumor, primary diffuse large B-cell lymphoma, angiolipoma, rhabdoid tumor). Finally, we identified 7 cases of primary kidney tumors with glomerular sparing pattern: 2 cases of clear cell renal cell carcinomas (ccRCC), 1 case of collecting duct carcinoma, 2 cases of urothelial carcinoma (UC), 1 case of diffuse large B-cell lymphoma and 1 case of malignant rhabdoid tumor. The primary kidney tumors with glomerular sparing pattern are rare and incidence in our study is <4% (7/204). There is no specificity for any tumor type, but more commonly seen in high grade UC rather than RCC. It can also be seen in rare neoplasms such as collecting duct carcinoma, lymphoma and malignant rhabdoid tumor. These GS cases need to be recognized as they are often associated with high grade, high stage, large tumor size, and worse prognosis.

Keywords: Glomerular sparing pattern; clinical; immunohistochemical study; morphological; primary kidney neoplasms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Renal cell carcinoma (RCC) with glomerular sparing (GS) pattern. A: Case #1, ccRCC; B: Case #2, ccRCC; C: Case #3, collecting duct carcinoma.
Figure 2
Figure 2
Urothelial carcinoma (UCa) with glomerular sparing (GS) pattern. A: Case #4 UCa with glandular differentiation; B: Double IHC stains of Pax8 (red) and P63 (brown); C: Case #5, UCa with extensive osteosarcomatous differentiation; D: The focal area with epithelioid features; E: IHC stain of GATA3; F: IHC stain of P63; G: IHC stain of CK5/6.
Figure 3
Figure 3
Diffuse large B cell lymphoma (DLBCL) with glomerular sparing (GS) pattern, case #6. A: H & E, section showed diffuse sheet growth pattern; B: IHC stain of Pax8 showed positive staining in entrapped renal tubule cells and DLBCL cells due to cross reaction of Pax5.
Figure 4
Figure 4
Malignant rhabdoid tumor (MRT) with glomerular sparing (GS) pattern, case #7. A: H & E, section showed similar diffuse sheet growth pattern of DLBCL in Figure 3A; B: Higher power view showed typical “rhabdoid” cytology; C: IHC stain of InI-1 showed loss of expression in MRT cells and retain expression in cells of glomerulus, vessel and stroma.

Similar articles

Cited by

  • Vessel co-option in cancer.
    Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR. Kuczynski EA, et al. Nat Rev Clin Oncol. 2019 Aug;16(8):469-493. doi: 10.1038/s41571-019-0181-9. Nat Rev Clin Oncol. 2019. PMID: 30816337 Review.

References

    1. Fukatsu A, Tsuzuki T, Sassa N, Nishikimi T, Kimura T, Majima T, Yoshino Y, Hattori R, Gotoh M. Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinoma. Am J Clin Pathol. 2013;140:500–505. - PubMed
    1. Das RN, Dasgupta S, Mondal S, Saha D, Chatterjee U. Diffuse large B-cell lymphoma of the kidney: a rare neoplasm. Indian J Pathol Microbiol. 2013;56:449–452. - PubMed
    1. Albadine R, Schultz L, Illei P, Ertoy D, Hicks J, Sharma R, Epstein JI, Netto GJ. PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am J Surg Pathol. 2010;34:965–969. - PMC - PubMed
    1. Gill-Samra S, Brooks A, P’ng CH. Sarcomatoid carcinoma involving the renal pelvis and ureter with heterologous osteosarcomatous differentiation. Pathology. 2012;44:367–369. - PubMed
    1. Reuter VE. Sarcomatoid lesions of the urogenital tract. Semin Diagn Pathol. 1993;10:188–201. - PubMed

LinkOut - more resources